stella
beta
RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study — Stella
Home
/
Radiomic
/
View on ClinicalTrials.gov
Recruiting
Back to Radiomic trials
Trial locations
(1 site)
Italy
Fondazione IRCCS Istituto Nazionale Tumori, Milan